Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Mitsubishi Tanabe Pharma

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 1
Rounds per year 0.07
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Clinical Trials
  • Biotechnology
  • Pharmaceutical
Summary

In 2007 was created Mitsubishi Tanabe Pharma, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Osaka. The company was established in Asia in Japan.

The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2013. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2008.

The standard case for the fund is to invest in rounds with 8 partakers. Despite the Mitsubishi Tanabe Pharma, startups are often financed by VenGrowth Asset Management, Novo Holdings, GeneChem. The meaningful sponsors for the fund in investment in the same round are VentureLink LP, VenGrowth Asset Management, Novo Holdings.

Among the most popular portfolio startups of the fund, we may highlight Cytochroma. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Clinical Trials. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AJI Capital Huntington, New York, United States
Brilliant Ventures California, Santa Monica, United States
euclid group Japan, Tokyo
Euro Sales Finance England, London, United Kingdom
Henan Guokong Fund Management China, Henan, Zhengzhou
Isetan Mitsukoshi Holdings Japan, Shinjuku
Jieyi Ziben Beijing, Beijing, China
Major League Baseball New York, New York, United States
MLS Capital Fund II -
Ningbo Xinrongji Touzi Youxian Gongsi China, Ningbo, Zhejiang
Paparelli Ventures Atlanta, Georgia, United States
Quoris California, San Diego, United States
Red Fort Capital -
Requus Ventures New York, New York, United States
Retailers lab -
Sembrador Capital Chile, Santiago Metropolitan Region, Vitacura
Sichuan Kaida Investment Development China, Gansu, Sichuan
SIMWON Kyonggi-do, Seongnam, South Korea
UMJ Japan, Tokyo

Notable deals

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mitsubishi Tanabe Pharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 35M
Rounds per year 0.07
Peak activity year 2008
Lead investments 1
Exits 1
Group Appearance index 1.00

Latest deals

Crunchbase icon

Content report

The following text will be sent to our editors: